2025 Best 10 API Suppliers in China

Introduction to API

Active Pharmaceutical Ingredients (APIs) are the key components in pharmaceutical products that are responsible for the intended therapeutic effects. They are the substances that give a drug its biological activity and are used in the formulation of various dosage forms such as tablets, capsules, and injections. The quality and safety of APIs are of utmost importance as they directly impact the efficacy and safety of the final pharmaceutical products. China has emerged as a major global supplier of APIs, with a large number of companies offering high - quality products at competitive prices. In this article, we will introduce the top 10 API suppliers in China in 2025.

1. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is a leading biopharmaceutical company in China that focuses on the research, development, production, and sales of genetic engineering drugs and APIs. The company was established in 1993 and has since then been at the forefront of biopharmaceutical innovation in China.

Company Introduction

Jiuyuan Genetic Biopharmaceutical has a state - of - the - art R & D center equipped with advanced facilities and a team of highly skilled scientists. The company's R & D efforts are mainly concentrated on the fields of cytokines, growth factors, and monoclonal antibodies. Their APIs are used in the treatment of a wide range of diseases, including cancer, autoimmune diseases, and infectious diseases.

The company has strict quality control systems in place. It adheres to international standards such as Good Manufacturing Practice (GMP) to ensure the quality and safety of its products. Jiuyuan Genetic Biopharmaceutical also has a strong commitment to environmental protection and sustainable development in its production processes.

API - related Features and Advantages

• Advanced Technology Platform: The company has established a series of advanced genetic engineering technology platforms, which enable it to efficiently develop and produce high - quality APIs. For example, its gene expression technology allows for the large - scale production of recombinant proteins with high purity and activity.
• Diverse Product Portfolio: Jiuyuan Genetic Biopharmaceutical offers a diverse range of APIs, including recombinant human interferon, recombinant human interleukin, and other cytokines. This wide product range meets the different needs of pharmaceutical manufacturers.
• Strong R & D Capability: With a professional R & D team, the company can continuously develop new APIs and improve the quality of existing products. It also actively cooperates with domestic and foreign research institutions to keep up with the latest trends in the biopharmaceutical industry.
• Quality Assurance: The company's strict quality control from raw material procurement to final product release ensures that its APIs meet the highest international standards. This has won the trust of many domestic and foreign customers.

Website: https://www.jiuyuangene.net/

2. Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd. is a well - known pharmaceutical company in China. It was founded in 1956 and has a long - standing history in the pharmaceutical industry.

Company Introduction

Hisun Pharmaceutical has a comprehensive industrial chain that covers R & D, production, and sales of APIs and pharmaceutical preparations. The company has a large - scale production base with advanced production equipment and strict quality management systems. It has a wide range of products, including anti - infective drugs, cardiovascular drugs, and anti - tumor drugs.

The company is committed to innovation and has invested heavily in R & D. It has established R & D centers in China and abroad, and has a large number of patents and independent intellectual property rights. Hisun Pharmaceutical also actively participates in international cooperation and has established long - term partnerships with many well - known pharmaceutical companies around the world.

API - related Features and Advantages

• Large - scale Production Capacity: Hisun Pharmaceutical has a large - scale production base, which enables it to produce APIs in large quantities. This gives it a cost - advantage in the market and ensures a stable supply of products.
• Rich Product Line: The company offers a wide variety of APIs, which can meet the different needs of customers in different therapeutic areas. For example, its anti - infective APIs are widely used in the global market.
• Global Market Presence: Hisun Pharmaceutical has a strong presence in the global market. Its products are exported to more than 100 countries and regions, which shows its high - quality products and strong market competitiveness.
• Quality and Regulatory Compliance: The company strictly adheres to international quality standards and regulatory requirements. It has obtained a series of international certifications, such as US FDA approval and EU GMP certification, which ensures the quality and safety of its APIs.

3. North China Pharmaceutical Group Corporation

North China Pharmaceutical Group Corporation is one of the largest pharmaceutical enterprises in China. It was established in 1953 and has a long - standing reputation in the pharmaceutical industry.

Company Introduction

The company has a complete industrial chain from raw material cultivation to API production and pharmaceutical preparation manufacturing. It has a large number of production bases and R & D institutions. North China Pharmaceutical focuses on the production of antibiotics, vitamins, and other APIs.

The company has a strong R & D team and has made significant achievements in the field of antibiotic research and development. It also pays great attention to environmental protection and has carried out a series of measures to reduce pollution in its production processes.

API - related Features and Advantages

• Antibiotic Expertise: North China Pharmaceutical is well - known for its antibiotic APIs. It has advanced production technology and a long - term experience in antibiotic production, which enables it to produce high - quality antibiotic APIs with stable quality.
• Integrated Industrial Chain: The company's integrated industrial chain allows for better control of raw material quality and production costs. This helps to ensure the competitiveness of its APIs in the market.
• Quality Control: North China Pharmaceutical has a strict quality control system throughout the production process. It conducts comprehensive quality inspections at every stage, from raw material inspection to final product testing, to ensure the quality and safety of its APIs.
• Research and Development Innovation: The company continuously invests in R & D to develop new antibiotics and improve the production technology of existing APIs. This helps it to stay ahead in the highly competitive antibiotic market.

4. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd. is a leading innovative pharmaceutical company in China. It was founded in 1970 and has grown into a large - scale pharmaceutical enterprise with a global influence.

Company Introduction

Hengrui Medicine focuses on the R & D, production, and sales of innovative drugs and APIs. The company has a world - class R & D center and a large number of high - level R & D personnel. It is actively involved in the research of new drugs in multiple therapeutic areas, such as oncology, anesthesia, and cardiovascular diseases.

The company has a modern production base that meets international standards. It also attaches great importance to intellectual property protection and has a large number of patents for its APIs and new drugs.

API - related Features and Advantages

• Innovative R & D Model: Hengrui Medicine has an innovative R & D model that combines in - house research with international cooperation. This allows it to quickly access the latest scientific research results and develop new APIs with high added value.
• High - Quality APIs for Oncology: The company is particularly strong in the field of oncology APIs. Its oncology APIs are known for their high quality and efficacy, and are widely used in the global oncology drug market.
• Global Clinical Trials: Hengrui Medicine conducts global clinical trials for its new drugs and APIs, which helps to ensure the safety and effectiveness of its products. This also enhances its international influence.
• Strong Brand Image: The company has a strong brand image in the pharmaceutical industry. Its commitment to quality and innovation has won the trust of customers around the world.

5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a large - scale pharmaceutical group in China. It was established in 1992 and has grown rapidly in the past few decades.

Company Introduction

Fosun Pharmaceutical has a diversified business model that includes R & D, production, and sales of APIs, pharmaceutical preparations, and medical devices. The company has a global layout, with production bases and R & D centers in China and abroad.

The company focuses on the development of innovative drugs and has a strong R & D team. It also actively promotes international cooperation and has acquired a number of well - known pharmaceutical companies and R & D institutions overseas.

API - related Features and Advantages

• Diversified Business Portfolio: Fosun Pharmaceutical's diversified business allows it to have a comprehensive understanding of the pharmaceutical market. This helps it to better develop and produce APIs that meet the market demand.
• Global Resources Integration: The company can integrate global resources through its international layout. It can access advanced R & D technologies and production facilities overseas, which is beneficial for the development and production of high - quality APIs.
• Strong Marketing and Distribution Network: Fosun Pharmaceutical has a strong marketing and distribution network both in China and globally. This enables it to quickly promote its APIs to customers around the world.
• Investment in Innovation: The company continuously invests in R & D and innovation. It encourages the development of new APIs and the improvement of existing products, which helps to maintain its competitiveness in the market.

6. Shandong Xinhua Pharmaceutical Co., Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd. is a time - honored pharmaceutical company in China. It was founded in 1943 and has a long history of API production.

Company Introduction

Xinhua Pharmaceutical mainly focuses on the production of APIs, pharmaceutical preparations, and chemical raw materials. The company has a large - scale production base with advanced production technology and equipment. It has a wide range of API products, including antipyretic analgesics, cardiovascular drugs, and anti - infective drugs.

The company has a strong R & D team and has carried out a series of technological innovations in API production. It also attaches great importance to environmental protection and has made remarkable achievements in reducing energy consumption and pollution in its production processes.

API - related Features and Advantages

• Long - standing Experience: With a history of more than 80 years, Xinhua Pharmaceutical has rich experience in API production. This experience allows it to better control the production process and ensure the quality of its APIs.
• Cost - effective Production: The company has optimized its production processes to achieve cost - effective production. This enables it to offer high - quality APIs at competitive prices in the market.
• Product Quality and Stability: Xinhua Pharmaceutical has a strict quality control system. It conducts strict inspections on raw materials, production processes, and final products to ensure the quality and stability of its APIs.
• Continuous Technological Innovation: The company continuously invests in technological innovation. It has developed a number of new production technologies and processes, which helps to improve the quality and production efficiency of its APIs.

7. Tianjin Tasly Pharmaceutical Co., Ltd.

Tianjin Tasly Pharmaceutical Co., Ltd. is a well - known traditional Chinese medicine and modern pharmaceutical company in China. It was founded in 1994 and has a unique position in the pharmaceutical industry.

Company Introduction

Tasly Pharmaceutical focuses on the R & D, production, and sales of traditional Chinese medicine (TCM) and modern APIs. The company has a large - scale TCM planting base to ensure the quality of raw materials. It also has a modern R & D center that combines traditional Chinese medicine theory with modern scientific research methods.

The company's products cover a wide range of therapeutic areas, including cardiovascular diseases, diabetes, and respiratory diseases. Tasly Pharmaceutical has a strong brand image in the domestic and international markets.

API - related Features and Advantages

• Traditional Chinese Medicine Heritage: Tasly Pharmaceutical has a deep understanding of traditional Chinese medicine. It can extract and purify active ingredients from traditional Chinese herbs to produce high - quality TCM - based APIs. This unique advantage allows it to offer products with special therapeutic effects.
• Integrated TCM Industry Chain: The company's integrated TCM industry chain, from herb planting to API production, ensures the quality and traceability of its products. This is highly valued in the market, especially for TCM - based APIs.
• Combination of Traditional and Modern Technologies: Tasly Pharmaceutical combines traditional Chinese medicine theory with modern scientific research and production technologies. This enables it to develop and produce APIs with both traditional efficacy and modern scientific support.
• International Market Expansion: The company has been actively expanding its international market. Its TCM - based APIs have attracted the attention of many foreign customers, which helps to promote the internationalization of traditional Chinese medicine.

8. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a large - scale pharmaceutical holding company in China. It was established through the reorganization of several well - known pharmaceutical enterprises in Guangzhou.

Company Introduction

The company has a diversified business structure, including the production and sales of APIs, pharmaceutical preparations, and health products. It has a large number of well - known brand products, such as Baiyunshan Jinguo Yinqiao Tablets.

Baiyunshan Pharmaceutical Holdings has a strong R & D team and is committed to the development of new drugs and APIs. It also pays attention to the protection of traditional Chinese medicine cultural heritage and the innovation of traditional Chinese medicine products.

API - related Features and Advantages

• Brand Advantage: The company has a number of well - known brand products, which gives it a strong brand influence in the market. This brand advantage helps to promote the sales of its APIs.
• Diversified Product Portfolio: Baiyunshan Pharmaceutical Holdings offers a wide range of APIs, including both Western medicine and traditional Chinese medicine - based APIs. This diversified product portfolio can meet the different needs of customers.
• R & D and Innovation: The company continuously invests in R & D and innovation. It actively explores new APIs and new production technologies, which helps to improve the competitiveness of its products.
• Industry Integration: Through its holding structure, the company can integrate various resources in the pharmaceutical industry. This integration helps to optimize the production process and reduce costs for API production.

9. Hualan Biological Engineering Inc.

Hualan Biological Engineering Inc. is a leading biopharmaceutical company in China. It was founded in 1992 and is mainly engaged in the research, development, production, and sales of biological products and APIs.

Company Introduction

Hualan Biological focuses on the production of blood products, vaccines, and other biological APIs. The company has a large - scale blood collection network and a modern production base. It has a strict quality control system for blood - derived products to ensure the safety of its APIs.

The company has a strong R & D team and is actively involved in the research of new biological APIs. It also attaches great importance to international cooperation and has established partnerships with some international biopharmaceutical companies.

API - related Features and Advantages

• Blood Product Expertise: Hualan Biological has rich experience in the production of blood - derived APIs. Its strict quality control in blood collection and processing ensures the safety and quality of its blood - based APIs.
• Vaccine R & D and Production: The company is also strong in vaccine R & D and production. Its vaccine - related APIs are developed with advanced technologies and strict quality control, which are widely used in the prevention of various diseases.
• Quality and Safety Assurance: Hualan Biological has a comprehensive quality and safety assurance system. It conducts strict inspections at every stage of production to ensure the safety and effectiveness of its biological APIs.
• Market Leadership in Biological Products: The company is a market leader in the field of biological products in China. Its strong market position helps to promote the sales and development of its APIs.

10. Shenzhen Neptunus Bio - Pharm Co., Ltd.

Shenzhen Neptunus Bio - Pharm Co., Ltd. is a high - tech biopharmaceutical company in China. It was founded in 1992 and has a focus on the R & D, production, and sales of biological APIs and pharmaceutical preparations.

Company Introduction

Neptunus Bio - Pharm has a modern R & D center and a production base that meets international standards. The company's R & D efforts are mainly concentrated on the fields of immune regulation, anti - tumor, and anti - virus. It has a number of independent intellectual property rights and patents for its APIs.

The company has a strict quality control system and is committed to providing high - quality products to customers. It also actively participates in social welfare activities and has a good social image.

API - related Features and Advantages

• Immune - related API Expertise: Neptunus Bio - Pharm has in - depth research and development in immune - related APIs. Its immune - regulating APIs are known for their high quality and efficacy, which are widely used in the treatment of various immune - related diseases.
• Advanced R & D Technology: The company uses advanced R & D technologies, such as gene engineering and cell culture technology, to develop and produce APIs. This enables it to produce high - purity and high - activity APIs.
• Quality - oriented Production: Neptunus Bio - Pharm adheres to strict quality control in its production process. From raw material selection to final product release, every step is carefully monitored to ensure the quality of its APIs.
• Market Competitiveness: The company's high - quality products and continuous innovation have given it strong market competitiveness. Its APIs are well - received in both domestic and international markets.

Conclusion

The above - mentioned 10 API suppliers in China represent the high - level of the Chinese pharmaceutical industry in 2025. These companies have their own unique features and advantages in API production, whether it is in terms of advanced technology, diverse product portfolios, strong R & D capabilities, or strict quality control. They not only meet the domestic demand for APIs but also have a significant presence in the global market. With the continuous development of the pharmaceutical industry, these companies are expected to play an even more important role in providing high - quality APIs for the global pharmaceutical market and promoting the progress of the entire industry. At the same time, they also face challenges such as increasing international competition, stricter regulatory requirements, and the need for continuous innovation. However, with their solid foundation and development potential, they are likely to overcome these challenges and achieve greater success in the future.